Pharmaceutical Product Information
Ocrevus® (ocrelizumab)
Healthcare Professionals
Product Information for Subcutaneous Administration (PI):
OCREVUS® VIALS 920 MG/23 ML
Product Information for Intravenous Administration (PI):
OCREVUS® VIALS 300 MG/10 ML
Should you face issues with accessing the product information, please contact us via:
Mondays to Thursdays: 8am to 5pm
Fridays: 8am to 3pm
Telephone: +603 76285600
Email: [email protected]
Solutions